PROFILELISTEXSALMONELEXTECHNOLOGYPUBLICATIONSNEWSINVESTOR RELATIONSCONTACT

SALMONELEX™

The Dutch Medicine Evaluation Board (College ter Beoordeling van Geneesmiddelen) has issued a Temporary Use Exemption for the use of SALMONELEX, Micreos Food Safety's first phage product against Salmonella. Field trials, aimed at product introduction in the course of 2012, are ongoing. 

For information on participation in possible trials you may contact us at info@micreos.com

SHARE THIS PAGE

NEWS

March 2012
EFSA confirms safety Listex against Listeria
More info 
November 2011
€ 1,24 million grant awarded to Micreos-headed consortium
More info
May 2011
USDA Approves LISTEX™ as a processing aid.
More info
March 2011
EU reports a sharp 19% increase in Listeriosis cases in the EU.
More info
January 2011
SALMONELEX™ approved by Dutch CBG for field trials.
More info
September 2010
Health Canada approves LISTEX™ as processing aid.
Download the PDF
July 2010
TNO Expert Opinion on safety of LISTEX™ P100.
Download the PDF
April 2010
EBI Food Safety appoints Wim Nuboer as Chief Operating Officer.
January 2010
LISTEX™ Significantly Reduces Listeria monocytogenes on Raw Salmon Fillet Tissue.
Download the PDF
More news

HIGHLIGHTS

NOTICE:
As of May 2011 EBI Food Safety will be changing it's name to MICREOS Food Savety.
LISTEX™ is

... approved as processing aid by:

and

LISTEX is:

... awarded best industry innovation:


"Phages: the future of food safety"

Feature article:

Bacteriophages, New Weapons for Food Safety

© Micreos Food Safety - 2012
DisclaimerContactSitemap